Mendelian randomization analysis using multiple biomarkers of an underlying common exposure.
Jin JinGuanghao QiZhi YuNilanjan ChatterjeePublished in: Biostatistics (Oxford, England) (2024)
Mendelian randomization (MR) analysis is increasingly popular for testing the causal effect of exposures on disease outcomes using data from genome-wide association studies. In some settings, the underlying exposure, such as systematic inflammation, may not be directly observable, but measurements can be available on multiple biomarkers or other types of traits that are co-regulated by the exposure. We propose a method for MR analysis on latent exposures (MRLE), which tests the significance for, and the direction of, the effect of a latent exposure by leveraging information from multiple related traits. The method is developed by constructing a set of estimating functions based on the second-order moments of GWAS summary association statistics for the observable traits, under a structural equation model where genetic variants are assumed to have indirect effects through the latent exposure and potentially direct effects on the traits. Simulation studies show that MRLE has well-controlled type I error rates and enhanced power compared to single-trait MR tests under various types of pleiotropy. Applications of MRLE using genetic association statistics across five inflammatory biomarkers (CRP, IL-6, IL-8, TNF-α, and MCP-1) provide evidence for potential causal effects of inflammation on increasing the risk of coronary artery disease, colorectal cancer, and rheumatoid arthritis, while standard MR analysis for individual biomarkers fails to detect consistent evidence for such effects.
Keyphrases
- rheumatoid arthritis
- genome wide
- coronary artery disease
- oxidative stress
- magnetic resonance
- air pollution
- healthcare
- dna methylation
- heart failure
- machine learning
- systemic lupus erythematosus
- metabolic syndrome
- percutaneous coronary intervention
- disease activity
- left ventricular
- electronic health record
- idiopathic pulmonary fibrosis
- coronary artery bypass grafting
- big data
- weight loss
- copy number